Pasithea Therapeutics Corp. (KTTA) IPO — S-1 Filing, Stock & Insider Activity

Pasithea Therapeutics Corp. IPO — Status & S-1 Filing

Track every registration update on the InsiderAlpha IPO tracker.

Updated Jul 16, 2026 · Last SEC filing 2026-06-22

Pasithea Therapeutics Corp. (KTTA) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 1 Form 8-K material event filings were reported by KTTA in the last 90 days. InsiderAlpha tracks every KTTA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Pasithea Therapeutics Corp. (KTTA)

SEC CIK0001841330

90-Day SEC Filing Activity

Form 4 filings (90d)8
Form 8-K filings (90d)1
Latest Form 4 filing2026-06-22

Recent KTTA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Coastlands Capital LP10% OwnerP — Open-market purchase100.0K$0.53$53KSEC
Leahy EmerDirectorA — Grant or award33.3K$0.75$25KSEC
Dumesnil SimonDirectorP — Open-market purchase33.3K$0.75$25KSEC
Marques TiagoChief Executive OfficerP — Open-market purchase33.3K$0.75$25KSEC
Schneiderman Daniel HChief Financial OfficerA — Grant or award26.7K$0.75$20KSEC
STEINMAN LAWRENCEDirectorP — Open-market purchase133.3K$0.75$100KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Pasithea Therapeutics Corp. (KTTA). Updated in real time as new filings are submitted to the SEC.

Most-Active KTTA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
STEINMAN LAWRENCE1
Schneiderman Daniel H1
Novak Alfred J1
Marques Tiago1
Leahy Emer1

Recent KTTA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KTTA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

KTTA Insider Trading — FAQ

What is the latest insider trade for KTTA?
Pasithea Therapeutics Corp. (KTTA) had 8 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying KTTA stock?
0 insider purchases of KTTA were filed in the last 90 days.
How many insiders are selling KTTA stock?
0 insider sales of KTTA were filed in the last 90 days.
Where can I see KTTA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every KTTA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live KTTA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.